AzTrials
AzTrials

ObesityPEFASNCT07009054

Program for the Promotion of Physical Exercise and Healthy Eating Among Population of Pakistani Origin With Obesity

A study testing Nutrition Education and Exercise in people with Obesity, run by Germans Trias i Pujol Hospital at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized control trial aims to evaluate the effectiveness of a culturally and linguistically adapted nutrition education and physical exercise program on lifestyle (diet and exercise), metabolic parameters, and fat content and distribution of people of Pakistani origin with obesity residing in the North… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Obesity
What is being tested?
Nutrition Education and Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteSpain
Study dates
3 Mar 2024to 30 Oct 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Being of Pakistani origin
  • Being Aged over 18 years
  • Having obesity, defined as BMI ≥ 27 Kg/m2
  • Being attended at the Saint Roc or Gorg Primary Care Centers, Endocrinology and Nutrition External Consultations at the Germans Trias i Pujol University Hospital (HUGTiP) or at the Specialized Care Center (Dr. Barraquer in St. Adrià and Dr. Robert in Badalona)
  • Voluntarily accepting participation in the study.

Who cannot join

  • Presenting a physical or mental illness that could prevent participation in the study.
  • Presenting any pathology that could limit life expectancy in the short term.
  • Pregnancy.
  • Having a close family member included in the project.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Hospital Universitari Germans Trias i Pujol

    Badalona, Barcelona, 08916

Other trials in Spain

About this study

Official title: Program for the Promotion of Physical Exercise and Healthy Eating (PEFAS) Culturally and Linguistically Adapted to the Population of Pakistani Origin With Obesity

This randomized control trial aims to evaluate the effectiveness of a culturally and linguistically adapted nutrition education and physical exercise program on lifestyle (diet and exercise), metabolic parameters, and fat content and distribution of people of Pakistani origin with obesity residing in the North Metropolitan health area of Barcelona. The betterment of the mentioned parameters is expected to be greater in individuals from the intervention group who will receive a total of 12 sessions of nutrition education and physical exercise compared to the control group who will participate in only 4 sessions.

Read the detailed description

This study aims to assess the impact of a culturally and linguistically adapted nutrition education and physical exercise program on the acquisition of heart-healthy habits (diet and exercise), various metabolic parameters (including glycemic and lipid markers), and the content and distribution of ectopic fat in individuals of Pakistani origin with obesity residing in the North Metropolitan Health Area of Barcelona.

A 6-week intensive randomized controlled trial (RCT) will be implemented with a total of 60 participants. Baseline data will be collected using both quantitative and qualitative methods by a multidisciplinary team of nutrition and nursing professionals. Quantitative methods will be employed to gather data on sociodemographic characteristics, health status, quality of life, clinical variables, body composition, eating habits, nutrition knowledge and skills, and physical activity. Qualitative methods will be used to adapt the intervention to the cultural and practical needs of participants and to explore variables such as eating habits and nutrition-related skills in greater depth.

Study data will be collected and managed using REDCap (Research Electronic Data Capture) tools hosted at Germans Trias i Pujol University Hospital.

Following baseline assessments, participants will be randomized into intervention (n=30) and control (n=30) groups using simple random assignment via a table of random numbers. The randomization sequence will be concealed in sealed, opaque envelopes labeled with participant codes.

The intervention group will receive one weekly theoretical-practical nutrition education session conducted in Urdu and one Nordic walking-based physical activity session per week, over a period of 6 weeks (totaling 6 nutrition sessions and 6 physical activity sessions). Nutrition education sessions will be conducted in the therapeutic kitchen of Germans Trias i Pujol University Hospital. Physical activity sessions will take place in public green spaces near participants' residential areas.

The control group will participate in two theoretical sessions of nutrition education and two sessions of physical activity.

After completion of the intervention (6 weeks), follow-up data collection will be conducted using the same quantitative and qualitative approaches applied at baseline. Follow-up assessments will also be repeated at 3 and 6 months post-intervention.

Conditions
Obesity
Being tested
Nutrition Education and Exercise, Usual Care Group
Keywords
obesity, metabolic syndrome, diet
Medical subject headings
Obesity, Metabolic Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nutrition Education and ExerciseBehavioural

    A 6-week intensive randomized controlled trial will be conducted with a total of 60 participants. Thirty participants will be assigned to the intervention group and thirty to the control group through simple randomization using a table of random numbers. The intervention group will receive one weekly theoretical-practical nutrition education session in Urdu and one physical activity session based on Nordic walking per week, for a total of six nutrition sessions and six physical activity sessions over the 6-week period.

  • Usual Care GroupBehavioural

    Also called Usual care

    The control group will participate in 2 theoretical sessions of nutrition education and 2 of physical exercise.

Study groups in NCT07009054
Study groupRoleWhat they receive
ActiveActive comparatorLife-style interventions (diet and exercise)
Receives: Behavioral: Nutrition Education and Exercise
ControlOtherUsual care
Receives: Behavioral: Usual Care Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fat mass and total body mass measured by bioimpedance analysis

    Body fat mass and total body mass will be quantified using bioimpedanciometry

    Measured: Baseline, 3 months and 6 months

  2. Thickness of superficial and pre-peritoneal fat (mm) measured by ultrasound of the rectus abdominis

    Subcutaneous and pre-peritoneal fat thickness will be assessed using ultrasound imaging of the rectus abdominis muscle.

    Measured: Baseline, 3 months, and 6 months

  3. Quadriceps muscle thickness (mm) measured by ultrasound

    Muscle mass will be evaluated through ultrasound measurements of the quadriceps muscl

    Measured: Baseline, 3 months, and 6 months

  4. Body Mass Index (BMI) in kg/m²

    BMI will be calculated as weight in kilograms divided by height in meters squared (BMI = kg/m²). Weight will be measured using a calibrated digital scale, and height will be measured with a portable stadiometer.

    Measured: Baseline, 3 months, and 6 months

  5. Waist circumference (cm)

    Waist circumference will be measured at the midpoint between the lowest rib and the iliac crest using non-stretchable tape, recorded to the nearest 0.1 cm with the participant standing.

    Measured: Baseline, 3 months, and 6 months

  6. Physical exercise

    The information related to the physical exercise will be gathered through the validated Urdu version of the International Physical Activity Questionnaire (IPAQ). Results will be reported as a continuous variable (MET minutes a week). Furthermore, participants from both the control and the intervention group will be provided with a smartwatch that will register their daily physical activity. The results will be presented in total minutes of intense and moderate physical activity per week.

    Measured: Baseline, 3 months and 6 months

  7. Health-related quality of life

    Perceived physical and mental health will be assessed using the 12-Item Short Form Survey (SF-12). The SF-12 is a self-reported outcome measure of health-related quality of life, widely used in various ethnic groups. It consists of 12 questions that are scored in various ways. The total score range is 12-47 (higher scores mean a worse outcome).

    Measured: Baseline, 3 months and 6 months

  8. Fasting glucose level (mg/dL)

    Fasting glucose will be measured in serum samples using enzymatic methods.

    Measured: Baseline, 3 months, and 6 months

  9. Hemoglobin A1C (%)

    HbA1c will be measured from whole blood using high-performance liquid chromatography (HPLC).

    Measured: Baseline, 3 months, and 6 months

  10. Insulin (mIU/L)

    Fasting insulin concentration will be measured using electrochemiluminescence immunoassay.

    Measured: Baseline, 3 months, and 6 months

  11. Aspartate aminotransferase (AST)(UI/L)

    AST will be measured via kinetic UV test using an automated analyzer.

    Measured: Baseline, 3 months, 6 months

  12. Alanine aminotransferase (ALT)(UI/L)

    ALT will be measured via kinetic UV test using an automated analyzer.

    Measured: Baseline, 3 months, 6 months

  13. Gamma-glutamyl transferase (GGT)(UI/L)

    GGT will be measured using enzymatic colorimetric methods.

    Measured: Baseline, 3 months, 6 months

  14. Total cholesterol (mg/dL)

    Total cholesterol will be measured using enzymatic colorimetric methods.

    Measured: Baseline, 3 months, 6 months

  15. LDL cholesterol (mg/dL)

    LDL-C will be measured directly via homogenous enzymatic assay.

    Measured: Baseline, 3 months, 6 months

  16. HDL cholesterol (mg/dL)

    HDL-C will be measured directly via homogenous enzymatic assay.

    Measured: Baseline, 3 months, 6 months

  17. Adherence to Mediterranean Diet using modified MEDAS questionnaire

    Adherence to the Mediterranean Diet will be assessed using a modified version of the 14-item Mediterranean Diet Adherence Screener (MEDAS), excluding the alcohol intake item (13 items total). Scores range from 0 to 13, with higher scores indicating better adherence. A score < 9 indicates low adherence; ≥ 9 indicates good adherence.. Unit of measure: score 0-13

    Measured: Baseline, 3 months, 6 months

  18. Nutrient intake measured by 24-hour Dietary Recall

    Nutrient and food group intake will be assessed using a structured 24-hour Dietary Recall (24HR), administered by trained staff. Data will be analyzed using nutritional analysis software to estimate daily intake. Unit of measure: grams, Kcal

    Measured: Baseline, 3 months, 6 months

Secondary outcomes (10)
  1. Sociodemographic data

    A survey will be administered in which the following data will be collected:place of birth, reason for migration, years of residence in Catalonia, members of the family unit, type of academic studies, occupation, languages known and spoken, religion practiced, center of origin, previous participation in similar programs.

    Measured: Baseline

  2. Clinical history

    The following clinical data will be collected with the help of the medical history: age, sex, presence of arterial hypertension (year of diagnosis and treatment), dyslipidemia (year of diagnosis and treatment), cardiovascular disease (ischemic heart disease, cerebrovascular disease, peripheral arterial disease) (age at diagnosis), DM (year of diagnosis, usual treatment), microvascular complications (retinopathy, nephropathy, neuropathy).

    Measured: Baseline

  3. Toxic habits

    Through the survey smoking habits and alcohol intake (UBEs/week) will be recorded.

    Measured: Baseline, 3 months and 6 months

  4. Nutrition knowledge

    Dietary knowledge will be evaluated in an ad hoc questionnaire of 14 questions related to some dietary aspects that will have three possible answers: true, false and I don't know. The focus groups will also include questions related to the dietary knowledge of the participants.

    Measured: Baseline, 3 months and 6 months

  5. Nutrition skills

    Dietary skills will be evaluated based on an ad hoc questionnaire of 13 questions that will analyze the degree of difficulty they have faced in carrying out different actions related to aspects of nutrition (planning, purchasing, preparation, etc.) during the last 15 days. These questions could be answered as follows: no difficulty (1 point), little difficulty (2 points), some difficulty (3 points), quite a bit of difficulty (4 points), and a lot of difficulty (5 points), with a minimum value of 13 points and maximum of 65 points. Higher scores will indicate greater difficulty in performing dietary tasks.

    Measured: Baseline, 3 months and 6 months

  6. Total sleep duration (minutes)

    Sleep duration will be objectively measured using a smartwatch device. Total minutes of sleep during the night will be recorded.

    Measured: Baseline and 3 months

  7. Sleep stages duration (minutes)

    Sleep stage data (light, deep, and REM sleep) will be recorded using a smartwatch, reporting the duration in minutes spent in each stage.

    Measured: Baseline and 3 months

  8. Sleep stages distribution (% of total sleep)

    The percentage of total sleep time spent in each sleep stage (light, deep, REM) will be calculated and reported.

    Measured: Baseline and 3 months

  9. Degree of hepatic steatosis measured by CAP (dB/m)

    Hepatic fat content will be assessed using the Controlled Attenuation Parameter (CAP) obtained via transient elastography (FibroScan®).

    Measured: Baseline and 6 months

  10. Liver stiffness measured by transient elastography (kPa)

    Liver fibrosis will be evaluated by measuring liver stiffness using transient elastography (FibroScan®).

    Measured: Baseline and 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jun 2025
  2. Study start3 Mar 2024
  3. Primary completion30 Oct 2024
  4. Study completion30 Oct 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07009054
Sponsor's protocol ID
PEFAS
Acronym
PEFAS
Status last verified
May 2025
First submitted
29 Nov 2024
Last updated
6 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Nutrition Education and Exercise in people with Obesity, run by Germans Trias i Pujol Hospital at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fat mass and total body mass measured by bioimpedance analysis (time frame: Baseline, 3 months and 6 months). The study lists 18 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in